Drug-drug Interaction Study of Ozanimod With Inhibitor or Inducer of CYP2C8 and/or CYP3A
Clinical trial NCT03624959 · COMPLETED
Trial details
- NCT number
- NCT03624959
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-20
- Primary completion
- 2018-08-10
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.